This algorithm outlines the steps for the provider to efficiently assess and manage a pregnant patient with cardiac arrest.
The provider must succeed in the following goals to successfully manage pregnant patients with cardiac arrest:
In-Hospital Cardiac Arrest in Pregnant Patient Algorithm
The team provides high-quality CPR and defibrillation to resuscitate the pregnant patient in cardiac arrest and follows other ACLS interventions as appropriate.
The critical difference in this resuscitation is that the maternal and neonatal teams are present during the resuscitation to care for the mother and newborn.
During the arrest, the team attempts to identify and treat the cause. Possibilities include:
The team provides 100% oxygen to the mother through a patent airway. The most experienced provider obtains and maintains the airway. A skilled provider initiates an IV above the level of the mother’s diaphragm.
If the mother is receiving magnesium, the team discontinues that infusion and administers calcium chloride or calcium gluconate.
The team continues to provide high-quality CPR and other ACLS interventions as appropriate.
As team members are providing ACLS interventions, the obstetrics team detaches any fetal monitors, maintains lateral uterine displacement, and prepares for the infant’s delivery by emergent cesarean section.
If the mother does not achieve ROSC within 5 minutes, the team leader must consider an immediate emergent cesarean section delivery.
Following delivery, the neonatal team assumes care of the infant.
The airway is more challenging to manage in pregnancy, due to altered anatomy, increase aspiration, and sudden-onset desaturation risk. The tilted position simply adds to these challenges. Ensure excellent use of bag-mask ventilations and suction in preparation for advanced airway.
Patients are at increased risk for sudden onset desaturation. Due to pregnancy-associated hyperventilation, ventilations are needed during compressions. Clinicians should have a low threshold for supplementing oxygenation and ventilation.
While traditional guidance was to place the hands more superiorly on the sternum, there is no good research supporting this and no evidence indicating that the heart is superiorly displaced in pregnancy. The usual hand placement is preferred. The major goals are to provide excellent chest compressions (Class I, Evidence level C-LD) and relieve IVC and aorta compression via displacement of the gravid uterus. (Class IIa, Evidence level C-LD)
While it has not been studied, it is reasonable to provide defibrillation to the pregnant patient in cardiac arrest. There is no significant difference in transthoracic resistance in pregnancy, and the standard doses can be used in pregnancy. There is a theoretical small increased risk of fetal arrhythmia; however, defibrillation is usually considered appropriate at any gestational age (GA).
Remove any fetal monitors before defibrillation as this will limit electric arcing and expediates cesarean delivery if imminent. (Class IIb, Evidence level C). Do not delay defibrillation for this purpose.
As ROSC may depend on delivery, appropriate resources should be made available whenever a pregnant woman in the latter half of pregnancy is found to be in cardiac arrest. (Class I, Evidence level C-EO). Routine training is important for achieving successful results in this complex and unusual situation. Utilize the algorithm for cardiac arrest in pregnancy for management. Class I, Evidence level C-EO).
Provide early attention to securing the airway due to physiological changes. Changes include edema, anterior displacement, increased aspiration risk, and increased bleeding with airway devices, including oro- and naso-pharyngeal airways. Some recommendations include
Ensure proper placement of the ETT using clinical signs and waveform capnography. Remember that while FRC is lowered, minute ventilation and tidal volume are increased. Ventilatory settings will need adjustment to support the physiology.
The ACLS recommendations for medications should be followed. While vasopressive medications like dopamine and epinephrine will reduce uterine blood flow, there are no good alternatives to these medications or doses. Remember that maternal recovery ultimately benefits the fetus.
Be aware of obstetric syndrome and conditions that may affect patient management. Abdominal ultrasound can be used to detect pregnancy (if unclear); do not delay acute management for this.
Sodium bicarbonate is not recommended routinely. In pregnancy, it can buffer the mother’s pH, but will not do so for the fetus and may obscure fetal acidosis.
Overdose is possible in women receiving magnesium therapy for eclampsia, especially if the woman has low urine output. Hypermagnesemia can lead to cardiac effects, including AV nodal block, bradycardia hypotension, and cardiac arrest. Neurologic effects include loss of reflexes, muscle weakness, and respiratory arrest. Stop any ongoing magnesium therapy and provide IV calcium therapy (15-30 mL 10% calcium gluconate or 5-10 mL calcium chloride).
This is the number one cause of maternal death and is rising.
Many pregnant patients may have congenital cardiac disease. This comorbidity is associated with increased risk for pregnancy complications, including arrest.
As women delay pregnancy to older ages, they are at increased risk of coronary artery disease. Pregnancy is a relative contraindication to fibrinolytic therapy, so PCI is the preferred treatment in STEMI.
This is a major cause of maternal death. This can be unrecognized until the woman has a cardiovascular compromise, especially in the postpartum period. Oxytocin is the treatment of choice for postpartum hemorrhage as it causes uterine contraction. However, the medication has side effects, including tachycardia, cardiac ischemia, hypotension, and arrhythmia. Also, it can precipitate fluid retention, resulting in hyponatremia, seizure, and coma. The use of oxytocin in the unstable cardiac arrest patient should be done cautiously.
Idiopathic cardiomyopathy of pregnancy is a significant cause of maternal mortality. It usually occurs in the post-partum period and up to 6 months after delivery.
These conditions lead to hypertensive related complications after 20 weeks’ gestation. Hypertension negatively affects maternal organs and can lead to placental insufficiency. In the case of eclampsia, this leads to seizures that can acutely threaten the lives of both mother and fetus.
Pregnancy physiology increases the risk of spontaneous aortic dissection. Comorbid conditions such as connective tissue disorders (i.e., Ehlers-Danlos, Marfan’s) increase the risk.
Pregnant women can have both pulmonary emboli and strokes as both conditions are increased with hormonal changes of pregnancy. Fibrinolytics have been reported in this case with successful maternal outcomes. Follow guidelines for the management of PE and stroke in these cases.
There are increased risks of anesthetics during pregnancy. Consequently, obstetric related anesthesia specialization has emerged. Regional anesthetics can precipitate spinal shock and result in cardiac arrest. At the same time, general anesthesia and routine intubation are more complicated in the pregnant patient.
Cardiopulmonary bypass has been reported to manage peripartum acute amniotic fluid emboli successfully. Cesarean delivery may be required at this time.
Pregnancy is not immune to these conditions. In fact, domestic violence is increased in pregnant women, and there is a real risk of homicide or suicide in this population. Additionally, post-partum depression may increase the risk of suicide attempts.